Aperam SA
OTC:APMSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aperam SA
OTC:APMSF
|
LU |
|
N
|
Natwest Group PLC
F:RYS1
|
UK |
|
Guardant Health Inc
NASDAQ:GH
|
US |
|
I
|
I-Tech AB
STO:ITECH
|
SE |
Wall St Price Targets
APMSF Price Targets Summary
Aperam SA
According to Wall Street analysts, the average 1-year price target for
APMSF is 49.1 USD with a low forecast of 30.1 USD and a high forecast of 67.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APMSF's stock price target?
Price Target
49.1
USD
According to Wall Street analysts, the average 1-year price target for
APMSF is 49.1 USD with a low forecast of 30.1 USD and a high forecast of 67.8 USD.
What is the Revenue forecast for Aperam SA?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 5 years is 12%.
What is the Gross Profit forecast for Aperam SA?
Projected CAGR
137%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 3 years is 137%.
What is the Operating Income forecast for Aperam SA?
Projected CAGR
103%
Over the last 14 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 5 years is 103%.
What is the Net Income forecast for Aperam SA?
Projected CAGR
109%
The compound annual growth rate for Net Income over the next 5 years is 109%.